SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

AKM Aspire Mining Limited

Basic Materials · Coking Coal · website
$0.22
52wk 0.18 – 0.32
Overall
31.8
Value
68.0
Growth
0.0
Health
50.0
Quality
0.0
Momentum
33.3
Dividend
—
Price
About Aspire Mining Limited

Aspire Mining Limited engages in the development of fat coking coal project in Australia and Mongolia. The company holds 100% interest in the Ovoot Coking Coal Project with mining license located in the Khuvsgul aimag province of north-western Mongolia. It also holds a 90% interest in the Nuurstei coking coal project that consists of mining license located in the Khuvsgul aimag province of north-western Mongolia. Aspire Mining Limited was incorporated in 2006 and is based in Sydney, Australia.

Commodity exposure

Primary exposure: Coal (detected from the company profile: coal, coking coal)

Coal primary
No direct price series on Yahoo Finance
Price analytics

Returns

1 day -8.3%
1 week -8.3%
1 month 7.3%
3 months 2.3%
6 months 0.0%
1 year -15.4%
3 years 171.6%

Risk

Volatility (1y ann.) 72.6%
Beta vs ASX 200 0.92
Sharpe (1y) 0.07
VaR 95% (1-day) -6.8%
Max drawdown (1y) -40.3%
Off 1-year high -29.0%

Technicals

RSI(14) 35
vs 50DMA 1.9%
vs 200DMA -7.1%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 68.0
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
83
Price / Sales
0
Growth 0.0
Revenue growth (1y)
—
Revenue CAGR (3y)
—
EPS growth (1y)
0
EPS CAGR (3y)
—
Financial Health 50.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 33.3
6-month return vs ASX 200
25
Price vs 200-day average
26
Price vs 50-day average
60
Position in 52-week range
29

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$111.68M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.02
Dividend yield
—
Payout ratio
0.0%
Beta
0.66
EV / EBITDA
-46.00
Price / Book
2.04
ROE
-17.1%
Operating margin
-3,702.0%
Net margin
0.0%
Total cash
$2.50M
Total debt
$0
Current ratio
16.28
Debt / Equity
—
Free cash flow
$-10.65M
Avg volume
43,892
Latest annual results (FY ending 31 Dec 2025)
  • Revenue—
  • Gross profit—
  • Operating income-$2.93M
  • Net income-$12.85M
  • Diluted EPS-0.03
  • Free cash flow-$8.64M
  • Net debt-$5.04M
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6